Paclitaxel delivery to brain tumors from hydrogels: a computational study

Area of Science:

• Biomaterials Science
• Neuro-oncology
• Drug Delivery Systems

Background:

• Malignant gliomas are aggressive brain tumors with poor prognoses.
• Current local treatment involves carmustine delivered via Gliadel® wafers.
• Novel polymer carriers are being developed to enhance drug delivery efficacy.

Purpose of the Study:

• To computationally investigate paclitaxel delivery from thermo-gelling polymer carriers.
• To compare the effectiveness of paclitaxel hydrogels with carmustine Gliadel® wafers.
• To identify key factors influencing controlled drug release from polymer implants.

Main Methods:

• Computational mass transport simulations were employed.
• Paclitaxel release from hydrogel carriers was modeled.
• Drug penetration depth and duration of therapeutic concentration were analyzed.

Main Results:

• Paclitaxel achieved similar therapeutic penetration distances (1-2 mm) as carmustine.
• Effective paclitaxel concentrations persisted for >30 days, versus 4 days for carmustine.
• Brain tissue convection hindered uniform drug distribution; gel surface area to volume ratio is critical.

Conclusions:

• Thermo-gelling polymers enable effective, long-term local paclitaxel delivery for malignant gliomas.
• These hydrogels represent a potential improvement over existing carmustine wafer treatments.
• Optimizing hydrogel design is crucial for sustained drug release and therapeutic outcomes.